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Abstract
Background: Eosinophilic esophagitis (EoE) is an immune-
mediated clinicopathological condition characterized by 
esophageal infiltration with eosinophils resulting in chronic 
inflammation and stricture. Summary: The recent increase 
in the incidence of EoE and the characteristic presentation of 
symptoms with difficulty swallowing and food bolus impac-
tion has raised key concerns of clinicians as well as research-
ers. EoE often presents with dysphagia, food impaction, nau-
sea, regurgitation or vomiting, and decreased appetite. It is 
more common in males, affecting both adults and children. 
The causative manner of this condition is complex and mul-
tifactorial. Throughout recent years, researchers have made 
a significant contribution to understanding the pathogene-
sis of EoE, genetic background, natural history, work on al-
lergy, and standardization in the evaluation of disease activ-
ity. There is relatively high prevalence of EoE among the pop-
ulation, emphasizing the importance of this disease. Key 
messages: Esophageal involvement with eosinophils may 
be manifested as isolated or with coexisting conditions and 
should be taken into consideration in the differential diag-
nosis. This study aimed to provide gastroenterologists with 
novel insights into the evaluation of esophageal involve-
ment with eosinophils and to pay special attention to the 
etiological factors, coexisting clinical diseases, and compli-
cations. © 2020 S. Karger AG, Basel
Introduction
Eosinophilic esophagitis (EoE) is a chronic, relapsing, 
immune-mediated esophageal disease [1–4] character-
ized by hyperplasia of basal cells, microabscesses, degran-
ulation, dilated intercellular spaces [5], and predominant 
eosinophilic infiltration in the esophagus [6]. The esoph-
agus is unique from the rest of the gastrointestinal tract; 
normally, there is no eosinophil in the esophagus. The 
prevalence is higher in both children and adults [1]. In 
EoE, high counts of eosinophil are build up in the epithe-
lial lining of the esophagus [7]. This eosinophilic buildup, 
which is a reaction to multiple factors including foods, 
allergens, atopic conditions, diseases, or acid reflux, may 
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deteriorate or damage the tissue of the esophagus which 
contributes to fibrosis and strictures [2, 8].
The symptoms of patients with EoE vary with age [9]; 
infants and toddlers most commonly have nausea, eme-
sis, abdominal pain, refusing eating, or not growing prop-
erly (failure to thrive) [3, 10, 11]. School-age children of-
ten experience recurrent abdominal pain or vomiting 
[12], and adolescents and adults have difficulty swallow-
ing, heartburn, and regurgitation most often [9, 13, 14] 
(Fig. 1).
Endoscopic characteristics of children with EoE in-
clude having either a normal appearance of esophageal 
tissue or plaques or edema findings, whereas adults dis-
play mucosal fragility, esophageal rings (trachealization), 
white exudates or plaques, longitudinal furrows, diffuse 
esophageal narrowing, and strictures (Fig.  2). EoE is a 
transmural disorder affecting all layers of the esophagus 
[15]. Histological identification of predominant eosino-
philic infiltration of >15 eosinophils per high-power field 
(HPF) is the diagnostic criterion [3, 8, 16, 17]. A mini-
mum of 3 or more biopsies from the proximal and distal 
esophagus should be collected for an adequate diagnostic 
yield [9, 18, 19].
Epidemiological Aspects
Over recent years, there has been a rise in the incidence 
and prevalence of EoE [20]. In both children and adult pop-
ulations, the prevalence has also increased. It is the leading 
cause of dysphagia in children and young adults [20].
It is estimated to be around 30–52 cases per 100,000 
inhabitants in the general population [21]. A research 
study between 2005 and 2011 in central Spain [22] found 
an average yearly incidence of 6.37/100,000 residents and 
a prevalence of 44.6/100,000 residents, the latter being 
greater in urban regions [23].
EoE has been described in all races and continents and 
can occur at any age, and it most commonly occurs in 
Caucasian males [24] and has a strong hereditary compo-
nent with large sibling risk ratio [11]. It is more frequent 
in males than in females (3:1). The mean age at the time 
of diagnosis ranges between 30 and 50 years in adults and 
5.4 and 9.6 years in children [25].
The pathogenesis of EoE is relatively poorly under-
stood. Increasing evidence suggests a strong involvement 
of genetic and environmental factors [26], premature de-
livery, cesarean birth, early antibiotic exposure, food al-
lergy, lack of breast feeding, and lack of early microbial 
exposure are associated with EoE [7, 11] (Table 1).
Mechanistic Aspects of Esophageal Damage in EoE
The mechanism of dysphagia in EoE is multifactorial, 
including mucosal stickiness, esophageal fibrosis, stric-
tures, and ring formation [27]. Eosinophils produce and 
release numerous proteins and mediators, namely, major 
basic protein, eosinophilic cationic protein, eosinophil-
derived neurotoxin, and eosinophilic peroxidase, which 
play a key role in tissue damage and remolding [28, 29]. 
Serum analyses of absolute eosinophil count, eosinophil-
Symptoms
• Infants and toddlers: Nausea, emesis, abdominal pain, failure to thrive 
• School-age children: Recurrent abdominal pain or vomi�ng
• Adolescents and adults: Dysphagia, heartburn and regurgita�on 
Endoscopic 
features
• Children: Normal appearance of esophageal �ssue or plaques or edema
• Adults: mucosal fragility, esophageal rings , white exudates or plaques, 
longitudinal furrows, diffuse esophageal narrowing, and strictures
Biopsy & 
Histology
• Biopsy: At least 3 or more biopsies from proximal and distal esophagus 
• Histology: Eosinophilic-infiltra�on of >15 eosinophils per high power field is   
the diagnos�c criterion 
Fig. 1. Clinical characteristics of patients 
with eosinophilic esophagitis.
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ic cationic protein, and eosinophil-derived neurotoxin 
were higher in EoE patients in one prospective study, be-
sides absolute eosinophil count predicted posttreatment 
eosinophilia [30]. Bone morphogenetic proteins [31] 
promote squamous differentiation of basal progenitor 
cells upon their activation in the adult’s esophagus, and 
basal cell hyperplasia in biopsy samples is associated with 
high levels of follistatin [32]. Activated eosinophil- and 
mast cell-derived transforming growth factor-β1 secre-
tion is crucial in EoE-associated tissue remodeling [33, 
34]; also, phospholamban, an integral membrane protein, 
is an important player in transforming growth factor-β1-
mediated esophageal squamous mucosa cell and myofi-
broblast contraction in the pediatric population [35].
Eosinophils and mast cells [36, 37] as well as histamine-
producing mast cells and basophils [38–40] play a very 
important role in bringing eosinophils into the esophageal 
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Fig. 2. Images of 3 patients (patient 1 (a–c); patient 2 (d, e); patient 3 (f)) with eosinophilic esophagitis in our 
endoscopic department show linear furrowing (a), mucosal friability and tearing (b), multiple nodules 0.2–0.3 
cm (c), trachealization (d), esophageal narrowing with exudates (e), and severe eosinophilic microabscess with 
linear furrowing (f).
Table 1. Epidemiology of eosinophilic esophagitis
Prevalence in both children and adults ↑
Dysphagia in children and young adults ↑
All races and continents Yes
Any age Yes
Commonly in Caucasian males Yes
Hereditary/sibling risk ratio ↑
Gender M > F
Mean age of diagnosis in adults 30–50 years
Mean age of diagnosis in children 5.4–9.6 years
Table 2. Mechanistic aspects of EoE
Proteins and mediators by eosinophils
Major basic protein
Eosinophilic cationic protein
Eosinophil-derived neurotoxin
Eosinophilic peroxidase
Bone morphogenetic protein
Phospholamban
Transforming growth factor-β1
Histamine-producing mast cells and basophils
Activated CD3+CD8+ T cells
Tumor necrosis factor-α
Interferon gamma
EoE, eosinophilic esophagitis.
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epithelium [39]. In the EoE-active group, a high number 
of activated CD3+CD8+ T cells were found to secrete tu-
mor necrosis factor-α and interferon gamma in compari-
son with the EoE-remission and control groups [18]. 
Moreover, the role of calcium-activated chloride channel 
Anoctamin 1 in esophageal cell proliferation and basal 
zone hyperplasia in EoE has also been reported (Table 2).
Etiological Factors
Certain conditions such as inflammatory mediators, ge-
netic susceptibility, environmental factors, atopic condi-
tions, dietary products, esophageal microbiome, and oral 
immunotherapy have been associated with a higher risk of 
EoE formation. However, various other conditions with 
distinct clinical and histological characteristics have also 
been identified to be associated with esophageal eosino-
philia such as eosinophilic gastrointestinal diseases, proton 
pump inhibitor (PPI)-responsive esophageal eosinophilia, 
drug hypersensitivity, pemphigus, connective tissue disor-
ders, graft-versus-host disease [41], and hypereosinophilic 
syndrome, a rare group of conditions that are associated 
with persistent high eosinophilia with eosinophil counts 
>1,500/μL, which most commonly affects the heart, central 
nervous system, skin, and respiratory tract [42].
Moreover, there is a hypothesis that medications such 
as acid suppressor (PPIs) might contribute to the patho-
genesis of EoE by preventing peptic digestion of food al-
lergens and altering microbial dysbiosis. EoE such as eo-
sinophilic gastroenteritis might have mucosal and muscle 
predominant types that may cause esophageal motility 
disorders including achalasia [43] (Table 3).
Inflammatory Mediators
EoE is still a relatively poorly understood entity. In-
creasing evidence indicates a vigorous presence of the in-
volvement of genetic and environmental factors [26]. The 
T helper type 2 (TH2)-mediated inflammatory cytokines, 
interleukin (IL)-4, IL-5, IL-13 [1, 3, 11, 15, 16, 44, 45], and 
IL-33 in pediatric [46], and invariant natural killer T cells 
[26] are involved in trafficking eosinophils into esopha-
geal tissue.
Activation of signal transducer and activator of tran-
scription-6 (STAT6) by IL-4 and IL-13 mediates the 
pathogenesis of allergic disorders [47, 48]. In experimen-
tal models, IL-13 has been demonstrated to induce esoph-
ageal eosinophilia and regulate numerous identified 
genes associated with EoE [11]. Moreover, epithelial cells 
and the thymic stromal lymphopoietin (TSLP) gene and 
its receptor appear to be risk factors for EoE as they un-
dergo polymorphisms in the eotaxin-3 [49–51] and other 
chemoattractants [15].
Genetic Susceptibility
Genetic associations are prone to various types of al-
lergic conditions, including EoE. The TSLP and cal-
pain-14 (CAPN14) are 2 widely studied genetic compo-
nents involved in EoE and atopy. Variants in the 5q22 
locus encoding the gene for TSLP have been associated 
with EoE and the most common atopic diseases, includ-
ing atopic dermatitis, asthma, and allergic rhinitis [20, 
52]. TSLP is an epithelial cell-derived cytokine that is se-
creted in response to allergen exposure on membrane 
surfaces and is involved in the initiation of type 2 inflam-
mation.
Table 3. Etiological factors associated with EoE
N Etiologies Associated factors Ref.
1 Inflammatory mediators TH2-mediated IL-4, IL-5, IL-13, IL-33 and TSLP [1, 3, 11, 15, 16, 44, 45]
2 Genetic susceptibility TSLP and CAPN14 [53]
3 Environmental factors Pollen seasons, cold or dry climate [57, 58]
4 Atopic conditions Asthma, allergic rhinitis, and atopic dermatitis [9, 63]
5 Dietary products Cow’s milk, soy, egg, wheat, peanut/tree nuts, seafood, and legumes [64–67]
6 Esophageal microbiome Haemophilus, Corynebacterium, Neisseria, Firmicutes and Bacteroides [20, 72]
7 Oral immunotherapy IgE-mediated food allergy (cow milk, egg, and shellfish) [74–76]
8 Inversely associated 
conditions
Helicobacter pylori and the development of EoE, and EoE versus Barrett’s 
esophagus
[11, 78]
9 Acid suppressor PPI → preventing peptic digestion of food allergens → alter microbial dysbiosis [43]
EoE, eosinophilic esophagitis; TH2, T helper type 2; IL, interleukin; TSLP, thymic stromal lymphopoietin; CAPN14, calpain 14; IgE, 
immunoglobulin E; PPI, proton pump inhibitors.
Etiological Factors, Coexisting Diseases, 
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In the esophagus, TSLP in biopsy samples from sub-
jects with EoE was found to be overexpressed as com-
pared with healthy individuals [52]. Similarly, variants in 
the 2p33 locus encoding the CAPN14 gene are strongly 
associated with EoE and atopy, with CAPN14 upregula-
tion in the esophagus among those with active esophagi-
tis or after exposure to type 2 cytokines [53]. Previous 
reports have also found the association of CAPN14 dys-
regulation with epithelial barrier dysfunction [54]. Like-
wise, these studies show a common set of genetic changes 
that may predispose an individual to various allergic 
manifestations, including EoE.
Environmental Factors
The rapid change in incidence and prevalence of EoE 
demonstrates the potential importance of environmental 
factors [11, 55]. Environmental allergen exposure may 
also play critical roles in the pathogenesis and ongoing 
manifestations of EoE, such as pollen seasons spring/fall 
or living in a cold or dry climate [11]. About the temper-
ate climate zone, studies reported an increased risk of EoE 
in patients residing in a cold climate zone [56]. While 
some of these studies suggest an association between sea-
son and EoE [57, 58], some studies have indicated no as-
sociation [59, 60].
Recently, a study related to seasonality and pollen 
counts was carried out in 36 EoE patients in the New York 
City area. The counts of 11 different pollen taxa were 
studied, including Acer (maple), Betula (birch), Populus 
(poplar), Ulmus (elm), Quercus (oak), Carya (hickory), 
Fraxinus (ash), Platanus (sycamore, London planetree), 
Fagus (beech), Poaceae (grass pollen family), and Ambro-
sia (ragweed). Increased patient symptoms were recorded 
in summer, and increased diagnoses were noted in the fall 
months. Moreover, symptoms of EoE correlated with 
peak levels of grass pollen [61]. Similarly, another study 
showed differences in the association between seasonality 
and EoE by climate zone, with the strongest evidence of 
seasonal variation in EoE diagnoses in temperate and 
cold climates. Higher EoE diagnosis was associated with 
summer months, but peak diagnoses varied by month de-
pending on the climate zone [55].
Besides, peripheral eosinophilia and elevated serum 
immunoglobulin E (IgE) levels are usually found in 50 
and 75% of patients [13], and there is no phenotypical 
variation in adult EoE with IgE-mediated food sensitivity 
and non-food-sensitive patients [62]. Together, these re-
sults point toward climate and geographic changes, sug-
gesting that aeroallergens may contribute to the develop-
ment of disease or flare.
Atopic Conditions
The majority of patients with EoE are atopic [2, 26, 44]. 
Most studies reported associations between EoE and 
atopic disorders. Patients with EoE are at increased risk 
of asthma, allergic rhinitis, atopic dermatitis, and food al-
lergies, suggesting potential common pathogenesis [25, 
63].
In general, eosinophils have been hypothesized to 
move to the esophagus in response to various ingested 
and/or inhaled allergens, thereby associating EoE with 
allergy-induced diseases. As a result of that, a high preva-
lence of atopic diseases (e.g., asthma, allergic rhinitis, and 
atopic dermatitis) and sensitization to food and environ-
ment allergens is seen in pediatric and adult EoE popula-
tions [9, 64].
The Role of Dietary Products in EoE
In the pathophysiology of EoE, food allergy is believed 
to play a crucial role [65–68]. However, the relationship 
between food allergy and EoE is complex. Allergy tests 
(skin tests, patch tests, or blood tests) are important. 
Many studies have shown that most EoE patients have 
evidence of IgE-mediated food sensitization based on 
IgE-specific in vitro or skin prick testing [64]. Once a food 
is eliminated from the diet of a patient, symptoms usu-
ally improve in a couple of weeks.
Foods such as dairy products, egg, soy, and wheat can 
cause an allergic disorder that is non-IgE mediated [44] 
and are the main causes of EoE. Wheat and cow’s milk are 
a commonly implicated trigger in EoE. Exclusive cow’s 
milk evading has recently been documented, and cow’s 
milk elimination induced clinicopathological remission 
in most EoE patients, endorsing its use as a first-line in-
tervention. However, a 6-food elimination diet targeting 
the common intact proteins is associated with food aller-
gies (cow’s milk, soy, egg, wheat, peanut/tree nuts, and 
seafood).
The recurrence of esophageal eosinophilia after the re-
introduction of food provides definite evidence of the role 
of food allergens in EoE [69]. A more tolerable 4- food 
elimination diet (dairy products, wheat, egg, and le-
gumes) was followed by adult EoE patients; after sequen-
tial reintroduction of food(s), only 1 or 2 foods were re-
ported as responsible for EoE in 65–85% of all EoE pa-
tients, regardless of age [68]. This approach has the 
benefit of shortening the time it takes to identify the 
food(s) responsible for EoE, meaning fewer endoscopic 
procedures.
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The Role of Esophageal Microbiome in EoE
The human microbiome is both immense and com-
plex, with 100 trillion microbes representing multiple 
genera colonizing the gastrointestinal tract alone [70]. 
Recently, the microbiome has been concerned with vari-
ous allergic and inflammatory diseases. The esophagus is 
colonized by hundreds of bacterial species, with members 
of the Firmicutes and Bacteroides phyla being among the 
highest in both children and adults [20].
The esophageal microbiome may play a vital role in 
EoE, especially Haemophilus[71, 72], Corynebacterium, 
and Neisseria[20, 73]. According to the study by Harris et 
al. [71], the average bacterial load detected in all subjects 
with EoE was significantly greater than that determined 
from normal subjects. By comparison, there was also a 
significant increase in the average bacterial load observed 
in gastroesophageal reflux disease (GERD) subjects com-
pared with normal esophagus control subjects.
Besides, alterations in the salivary microbiome have 
also been reported in EoE [72]. The associations between 
early-life environmental pressures and the development 
of EoE existed. For example, antibiotic exposure and diet 
known to influence and alter normal esophageal flora are 
associated with EoE in the majority of studies. Similarly, 
cesarean delivery also increases the risk of EoE. Such find-
ings together support the role of environmental pressures 
that modify the microbiome, leading to the development 
of EoE and other allergic manifestations. To expand upon 
this work and identify the most relevant microbes and 
involvement of immunological mechanisms, however, 
future research is necessary.
Oral Immunotherapy and EoE
Recently, the increasing number of EoE detection in 
patients undergoing oral immunotherapy (OIT) for IgE-
mediated food allergy has raised serious concerns that 
OIT may elicit EoE in susceptible individuals. This asso-
ciation was further investigated in a meta-analysis show-
ing a positive correlation between OIT and EoE, with the 
occurrence of new onset in 2.7% of OIT patients [20, 74]. 
However, it is uncertain at present whether OIT triggers 
EoE or whether OIT aggravates moderate EoE in other-
wise subclinical individuals.
The prevalence of EoE was observed higher in patients 
with IgE-mediated food allergy than in the general popu-
lation [75], and the history of IgE-mediated food allergy 
to the 3 common food allergens (milk, egg, and shellfish) 
was closely linked to the subsequent diagnosis of EoE 
[75]. Gómez Torrijos et al. [76] reported 57 children who 
underwent OIT for cow milk allergy in which 3 of them 
were diagnosed with EoE and asymptomatic esophageal 
eosinophilia after a cow milk-free diet. Moreover, the au-
thor also stated that all patients allergic to cow milk who 
underwent OIT developed EoE, showed unfavorable 
progress, and required a dose reduction of cow milk.
In one follow-up study, a hazardous ratio of 9.1 for 
children with IgE-mediated food allergy in developing 
EoE was observed, the strongest association was detected 
among the various allergic march relationships [77]. Such 
findings together indicate that both IgE-mediated food 
allergy and EoE may result from a common allergen-spe-
cific TH2 response. Furthermore, the concern for iatro-
genic EoE in patients undergoing OIT is warranted, and 
patients undergoing OIT should be strictly monitored for 
EoE symptoms.
Inverse Relationship between EoE and Helicobacter 
pylori
An interesting inverse association between EoE and H. 
pylori[11] and an inverse relationship between H. pylori 
and the development of EoE were established in recent 
studies taking into account that environmental factors 
might influence the development of EoE [56, 78]. Fur-
thermore, H. pylori infection has been found to be in-
versely related with atopic diseases (asthma, atopic der-
matitis, and allergic rhinoconjunctivitis) and may play a 
protective role in these conditions [63]. Similarly, an in-
verse relationship between EoE and Barrett’s esophagus 
has also been reported in a Japanese study [79]. A study 
by Dellon et al. [80] reported an inverse relationship of 
esophageal eosinophilia and H. pylori infection (OR 0.77) 
in esophageal biopsy samples accumulated from a US pa-
thology database. Also, the analysis showed that odds of 
H. pylori infection decreased as esophageal eosinophilia 
increased (OR 0.52 for >90 eosinophils/HPF).
Moreover, von Arnim et al. [63] reported serological 
analyses for H. pylori infection in 58 patients with clini-
cally and histologically proven EoE. Among them, 3 pa-
tients reported with current H. pylori infection and 5 pa-
tients reported with previous eradication therapy for H. 
pylori infection as serologically negative posteradication 
therapy status. EoE patients with current H. pylori infec-
tions displayed a significantly lower prevalence than the 
control groups. EoE (current and former) was strongly 
inversely associated with seroprevalence of H. pylori (OR 
0.24, 95%).
Recently, a large multicenter case-control study 
straightly examined the relationship between H. pylori 
and EoE in a prospective manner. A total of 808 individ-
uals, including 170 children, were studied. The study 
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found no difference in H. pylori prevalence between cases 
and control groups in either children or adults [81]. A 
possible correlation between EoE and H. pylori infection 
has not been sufficiently investigated in the literature and 
therefore requires further study and discussion.
Comorbid Conditions
EoE is a chronic, allergic, immune system-mediated 
disease associated with an increased risk of comorbid 
conditions (Table 4).
Possible Relationships between GERD and EoE
Over the past 2 decades, esophageal eosinophilia has 
progressed from a clinical criterion of GERD to an ulti-
mate histological marker of EoE and now back to an actu-
ally complex association between the 2 entities. The in-
creasing GERD reports in the general population are high 
enough to make the coexistence of GERD with EoE in-
evitable. EoE and GERD have overlapping clinical, endo-
scopic, manometric, and histopathologic features. EoE 
may contribute to the development of GERD via many 
eosinophil products that can relax the muscle of the low-
er esophageal sphincter as a result altering motility or 
causing structural changes. In contrast, GERD causes 
EoE, leading to acid injury of the epithelium, increased 
epithelial permeability, and increased immune cells re-
cruitment [26, 67, 82].
EoE is commonly seen in dysphagic patients and, to a 
lesser extent, PPI-resistant GERD [64]. According to the 
study by Zukerberg et al. [83], patients with EoE (mean 
peak eosinophil count of 53/HPF) showed increasingly 
higher intraepithelial eosinophilic numbers than those 
with reflux esophagitis (mean peak eosinophil count of 
27/HPF).
In general, patients with EoE demonstrate diffuse 
esophageal involvement (as measured by the number of 
eosinophils), while reflux esophagitis is usually confined 
to the distal part of the esophagus. Moreover, the study 
stated that patients with EoE showed significant submu-
cosal fibrosis and abscesses which composed of eosino-
phils.
The literature by García-Rojo et al. [40] reported that 
CD3-, CD4-, and CD8- marker analysis may be used to 
distinguish between GERD and EoE patients. In rare situ-
ations, for example, children with strong clinical suspi-
cion where fragments do not reach 15 intraepithelial eo-
sinophils/HPF, immunostaining for arachidonate-15 li-
pooxygenase has been found to be a sensitive marker for 
EoE [84]. Moreover, von Arnim et al. [85] reported 10 
characteristic marker set (atopy, food impaction, dyspha-
gia, PPI-refractory symptoms, peripheral eosinophilia, 
IgE, weight loss, painful swallowing/odynophagia, age, 
and sex) which effectively distinguish GERD from EoE. 
Besides, the 10 markers were further reduced to 4 param-
eters (history of atopy, history of food impaction, PPI-
refractory symptoms, and either IgE or peripheral eosin-
ophilia), which were also able to excellently predict EoE 
and differentiate EoE from GERD.
In refractory GERD patients, EoE is not uncommon. 
It may exist with symptoms of dysphagia, heartburn, and 
the impaction of food. Esophageal screening with biopsy 
is necessary for older patients with longstanding GERD, 
positive for atopy, or not responding to gastric acid in-
hibitors.
EoE and Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) and EoE are chron-
ic inflammatory disorders associated with an impaired 
mucosal immune response; however, the immune re-
sponses are different. EoE is believed to be an antigen-
driven allergic disorder in genetically predisposed indi-
viduals mediated by TH2 cells, which contributes to eo-
sinophil migration into the esophageal mucosa. In 
contrast, IBD is regarded as multifactorial. More recently, 
the coexistence of EoE and IBD has been increasingly rec-
ognized [66, 86, 87]. Talathi et al. [86] reported a case se-
ries of 6 pediatric patients with coexisting EoE and IBD 
(4 Crohn’s disease and 2 ulcerative colitis), which re-
vealed characteristic endoscopic and histological findings 
suggestive of EoE.
Table 4. Coexisting conditions with EoE
GERD
IBD (Crohn’s disease and ulcerative colitis)
CD
Lymphocytic esophagitis
Eosinophilic cholangitis
Type 2B von Willebrand disease
Esophageal intramural pseudo diverticulosis
Vascular changes in eosinophilic esophagitis
Immunoglobulin G4-related disease
Herpetic esophagitis
Esophagitis dissecans
Siderius-Hamel syndrome
EoE and eosinophilic subserosal gastroenteritis with ascites
EoE, eosinophilic esophagitis; GERD, gastroesophageal reflux 
disease; CD, celiac disease; IBD, inflammatory bowel disease.
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Regarding the gastrointestinal tract, eosinophilia is 
common in IBD and the number of eosinophils is reliant 
on the severity of the disease. Recent studies reported a 
progressively complex course in patients with concurrent 
IBD and EoE, which includes IBD-related complications, 
poor response to infliximab, and poorer nutritional out-
comes [87].
This study underlines the need for physicians to con-
sider the possibility of concurrent EoE and IBD, particu-
larly when the eosinophilic condition is isolated to the 
esophagus in patients with IBD and the existence of other 
histological features related EoE. Such understanding will 
help in the early diagnosis and management of these pa-
tients and also help to better understand the relationship 
between these 2 conditions.
EoE and Celiac Disease
Celiac disease (CD) and EoE have recently been the 
main focus of various pediatric studies with variable out-
comes. Both diseases are mediated by the immune sys-
tem, and dietary factors play a significant role in their 
pathogenesis. When untreated, both diseases lead to the 
destruction of the epithelium [88]. Both celiac disease and 
EoE need biopsy results for diagnosis, and both condi-
tions may occur despite an utterly normal appearance of 
the mucosa [89].
One study reported the initial endoscopic evaluation 
of 10 children with coexisting CD and EoE on histopath-
ological findings; their symptoms improved after a glu-
ten-free diet, topical glucocorticosteroid, and elimination 
diet [88]. Patton et al. [90] reported a cohort of 22 patients 
diagnosed with CD and EoE, in whom soy was well toler-
ated, and suggested that reintroduction of this food first, 
or trialing a soy-inclusive dietary elimination is a viable 
strategy. Moreover, Vaz et al. [91] reported a patient with 
characteristic features of EoE and underwent topical and 
systemic corticosteroids, in whom repeated endoscopy of 
the duodenal mucosa showed multiple papules and the 
biopsies’ results were consistent with CD. Furthermore, 
Ari et al. [92] evaluated both isolated CD and EoE and 
combined CD + EoE and stated that these are 2 coexisting 
entities in patients who present with combined CD + EoE 
and they share certain characteristics with their counter-
parts with isolated CD and EoE.
According to Wallach et al. [89], there is greater adher-
ence to guidelines for biopsy in which celiac disease and 
EoE are ultimately diagnosed. The diagnoses of both CD 
and EoE are associated with adequate adherence to the 
guidelines, and detection rates of the disease increase with 
increased mucosal sampling.
EoE and Lymphocytic Esophagitis
Lymphocytic esophagitis most commonly present 
with symptoms of dysphagia, abdominal pain, heartburn, 
and nausea. Endoscopic features of lymphocytic esopha-
gitis can be similar to EoE including esophageal rings, 
furrows, exudates, narrow lumen, or stenosis, but in one-
third of patients, the esophageal mucosa appears macro-
scopically normal [93].
Lymphocytic esophagitis is diagnosed when more 
than 40 intraepithelial lymphocytes/HPF are present and 
no intraepithelial granulocytes or occasional presence of 
CD15 + intraepithelial granulocytes. The compound eo-
sinophilic and lymphocytic esophagitis can be considered 
in patients who fulfilled both EoE and lymphocytic 
esophagitis diagnostic criteria (>15 eosinophils/HPF and 
>40 intraepithelial lymphocytes/HPF) [93, 94].
EoE and lymphocytic esophagitis can sometimes be 
considered as an overlapping phenotype of endoscopic 
features similar to that in EoE when there are over 40 in-
traepithelial lymphocytes/HPF present [93, 94]. Accord-
ing to the study by Truskaite et al. [93], compound EoE/
lymphocytic esophagitis show the leading cause of food 
bolus impaction in patients ˂50 years of age.
Relationship between EoE and Eosinophilic 
Cholangitis
Eosinophilic cholangitis is a rare condition defined as 
an eosinophilic infiltration of the biliary tree that can lead 
to fibrosis, stricture, and biliary obstruction. Recently, 
Tanaka et al. [95] reported a 70-year-old female with eo-
sinophilic cholangitis with a past history of EoE, who was 
treated with prednisolone (2.5–7.5 mg/day) for 1 year. 
She was negative for the hepatitis virus and IgG4 staining. 
However, marked eosinophilic infiltrates were seen on 
her biliary biopsy in the common bile duct (60 cells/HPF). 
She was started with prednisolone 30 mg/day and tapered 
the dose to 2.5 mg/day, and she was asymptomatic with-
out common bile duct wall thickening.
EoE and Type 2B von Willebrand Disease
von Willebrand disease is the most common heredi-
tary blood-clotting disorder in humans. There are 4 he-
reditary types: type 1, type 2, type 3, and pseudo or plate-
let-type. Type 2 is subdivided into 4 types: 2A, 2B, 2M, 
and 2N.
A case study by Corder et al. [96] reported a 20-year-
old female with type 2B von Willebrand disease with an 
8-year history of solid food dysphagia. Type 2B von Wil-
lebrand condition is characterized by qualitative defects 
in the “von Willebrand factor” structure or function. She 
Etiological Factors, Coexisting Diseases, 
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had a history of bleeding ranging from recurrent epistax-
is, easy bruising, gum bleeding, prolonged menses, and 2 
severe episodes of hemoperitoneum secondary to a rup-
tured ovarian cyst requiring hospitalization. Her initial 
endoscopy revealed longitudinal furrows, white plaques, 
and edema throughout the esophagus with a severe focal 
stricture at the gastroesophageal junction. Esophageal bi-
opsies revealed increased eosinophils in both the proxi-
mal (60 eosinophils/HPF) and distal esophagus (80 eo-
sinophils/HPF). She underwent multiple balloon dilation 
13.5–18 mm with preprocedure and postprocedure pro-
phylaxis of human plasma-derived von Willebrand factor 
(HP-vWF-FVIII) concentrate prophylaxis.
Esophageal Intramural Pseudodiverticulosis
It is a rare idiopathic benign condition characterized 
by a flask-like outpouching of the esophageal wall that is 
distinguished by dilatation and inflammation of excre-
tory ducts within submucosal glands of the esophagus. 
Patients with EoE and pseudodiverticulosis had signifi-
cantly more food bolus obstructions.
Few cases have been reported on concomitant EoE 
with pseudodiverticulosis. Scaffidi et al. [97] documented 
5 patients with pseudodiverticulosis who had endoscopic 
findings suggestive of EoE and met the histological crite-
ria of ≥15 eosinophils/HPF.
Patients with EoE tend to have pseudodiverticulosis 
within the mid-to-distal esophagus, whereas patients 
without EoE had pseudodiverticula primarily in the prox-
imal esophagus. Moreover, Kathi et al. [98] reported an 
endoscopic and biopsy findings of a patient with dyspha-
gia and gastroesophageal reflux disease who was found to 
have an esophageal pseudodiverticula along with EoE.
Vascular Changes in EoE
The changes in the vascular structure and function and 
their association in hypertension can sometimes severely 
damage blood vessels, which can lead to a significant nar-
rowing of blood vessels and ischemia in various tissues. 
Mahjoub et al. [99] reported an esophageal biopsy of a 
pediatric patient with EoE overlying small arteries within 
the lamina propria showed markedly thickened media 
with medial hypertrophy to the point of obstruction.
Moreover, Frech et al. [100] reported EoE patients 
with diffuse cutaneous systemic sclerosis, Raynaud’s, and 
skin thickening, one had facial telangiectasia and another 
had early interstitial lung disease. The gastrointestinal 
tract, especially the esophagus, is most commonly affect-
ed by systemic sclerosis.
Immunoglobulin G4-Related Disease
The role of immunoglobulin G4 (IgG4) in the develop-
ment of EoE is unclear. There are predominant IgG4-as-
sociated plasma cells up to 180–300/HPF in the deep lam-
ina propria in adult EoE, not an IgE-induced allergy 
[101–103].
According to the study by Clayton et al. [101], esopha-
geal deposits of IgG4 in EoE arise from dense plasmacyt-
ic infiltrates in the lamina propria, which shows abundant 
IgG4-containing plasmacytes, and IgG4 serum levels re-
active to particular foods, indicating that EoE in adults is 
IgG4-associated. Moreover, Zukerberg reported 58 and 
40% of cases with EoE and GERD that were positive for 
mucosal IgG4 plasmacytes, indicating that the presence 
of intrasquamous IgG4 deposits is a useful adjunctive 
marker in differentiation between GERD and EoE pa-
tients [83, 104, 105].
These findings indicate the possible associations be-
tween EoE and IgG4-related diseases. However, fibrosis 
is a characteristic feature of both IgG4-related disease and 
EoE, although the quality and the pattern of fibrosis are 
generally different: IgG4-related disease is characterized 
by fibrosis of the storiform type, whereas EoE has a pat-
tern-less fibrosis pattern [2, 104].
Herpetic Esophagitis with EoE
Herpes simplex esophagitis is an acute and severe viral 
infection of the esophagus, rarely seen in individuals with 
immunocompetence. Various studies indicated a possi-
ble link between herpes simplex virus infection/esopha-
gitis and EoE [11].
Both entities can be diagnosed simultaneously or one 
prior to the other, raising a possible causal relationship 
[106, 107]. A study by Fritz et al. [106] retrospectively 
evaluated 5 immunosuppressed and 11 immunocompe-
tent herpetic esophagitis patients’ data. After herpes sim-
plex infection, the 5 immunosuppressed patients had re-
peated biopsies, which revealed eosinophilic infiltration 
in accordance with current EoE diagnostic criteria. How-
ever, EoE was a comorbid in almost half of the 11 immu-
nocompetent patients. Similarly, a series of 5 adult pa-
tients with herpes simplex esophagitis had histological 
and clinical symptoms consistent with the diagnosis of 
EoE [108]. Kim et al. [109] reported an 11-year-old Ko-
rean boy suffering from fever, odynophagia, dysphagia, 
and chest pain. His upper endoscopic examination of the 
distal esophagus revealed longitudinal ulcers with volca-
nic appearance. The test results for a polymerase chain 
reaction and biopsy samples were found positive for her-
pes simplex virus type 1. He received acyclovir and PPIs, 
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but the follow-up esophagoscopy demonstrated typical 
EoE patterns and the biopsies were consistent with the 
EoE diagnostic criteria. For immunocompetent patients 
with herpetic esophagitis, especially those with atopic 
conditions, clinical follow-up is therefore required.
Esophagitis Dissecans with EoE
Esophagitis dissecans superficialis and EoE are dis-
tinctive esophageal conditions with characteristic clinical 
and histological findings. Esophagitis dissecans superfi-
cialis is an unusual endoscopic finding consisting of peel-
ing large esophageal mucosa fragments. Esophagitis dis-
secans patients may vomit casts of sloughed-off esopha-
geal mucosa, while others may present with dysphagia, 
epigastric pain, or heartburn.
Guerra et al. [110] reported a patient with both esoph-
agitis dissecans and EoE with significant mid-esophageal 
findings of gross abnormality of ulcerations, furrowing, 
streaks of white layering of mucosa with sloughing, and 
friability. Severe esophagitis was observed on histology 
with marked squamous epithelium infiltration of neutro-
phils and eosinophils and mucosal separation with bul-
lous spaces and ulceration. These findings together sig-
nify that esophagitis dissecans might be another unspe-
cific finding of EoE and the differential should be 
considered while encountering such conditions.
Siderius-Hamel Syndrome
It is characterized by intellectual disability and distinct 
facial features. Recently, a triple association of (Crohn’s 
disease, celiac disease, and EoE) was reported in a child 
with Siderius-Hamel syndrome [111]. Thus, physicians 
should be aware of this rare occurrence while evaluating 
patients with Siderius-Hamel syndrome.
Eosinophilic Subserosal Gastroenteritis with Ascites
A recent study of a 30-year-old woman with increased 
peripheral eosinophilia, IgE, and tumor marker Ca-125 
revealed increased thickening of the esophageal and small 
bowel wall with ascites as well as marginally narrowed 
esophageal lumen with eosinophils >15/HPF [112].
Complications
EoE is a prolonged esophageal inflammatory condi-
tion with persistent or spontaneous course of instability. 
So far, life expectancy does not seem to be affected, but it 
often affects the quality of life. To date, no association be-
tween esophageal cancer and EoE was found [113]; how-
ever, there are major concerns that the prolonged, uncon-
trolled inflammation may cause irreversible structural 
changes in the esophagus, resulting in tissue fibrosis, 
stricture formation, and impairment of the esophageal 
function (Table 5).
Inflammatory Conditions
EoE may present with an inflammatory phenotype, 
such as furrows, white exudates, and edema, or strictur-
ing phenotype (rings and stenosis) [14], or a combination 
Table 5. Complications associated with EoE
Conditions Characteristics
Inflammatory conditions Furrows, white exudates, edema, esophageal rings, and stenosis
Esophageal perforation Boerhaave syndrome, fibrostenotic condition, and esophageal dilatation
Hepatic portal venous gas Intraluminal gas enters the portal venous circulation due to endoscopic dilation for benign esophageal 
strictures with EoE
Intramucosal dissection of 
the esophagus
Inflammatory conditions → separation of mucosa and/or submucosa → false lumen
Esophageal dysmotility Esophageal mucosa infiltration by eosinophils and their interactions with the microenvironment and 
inflammatory cytokines
Achalasia-like changes Esophageal muscularis propria → abnormally buildup of eosinophils → myoactive and neuroactive 
eosinophilic secretory products → cytotoxic eosinophil secretory products
Adrenal insufficiency Low morning serum cortisol levels
EoE, eosinophilic esophagitis.
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of them. In this regard, partial or complete esophageal 
obstruction due to esophageal scarring and narrowing or 
food impaction and eating difficulties are 2 important 
complications of EoE and is a medical emergency [93].
Esophageal Perforation
Perforation of the esophagus is a potentially serious 
complication of EoE. To date, a few cases of spontaneous 
esophageal perforation have been reported in patients 
with EoE, also known as Boerhaave syndrome. The pres-
ence of eosinophilic infiltrates is the possible mechanism 
that causes epithelial inflammation to progress toward fi-
brostenotic condition that leads to esophageal remodel-
ing. This remodeling potentially deteriorates esophageal 
motility and often leads to dysphagia and food impaction, 
and spontaneous perforation may occur as damage prog-
ress [114–116]. Moreover, Gisasola et al. [4] reported a 
patient with mediastinal abscess secondary to EoE with-
out trauma, perforation, or previous surgery.
It is important to note that vomiting-induced esopha-
geal perforation is a potentially serious complication of 
EoE. Therefore, EoE should be evaluated in patients with 
nontraumatic Boerhaave syndrome, especially young 
men with a prior history of dysphagia and allergies.
Endoscopic interventions for alleviating food impac-
tion may result in complications such as esophageal per-
foration due to the friability of the esophageal mucosa 
[116]. Because of chronic inflammation of the esophagus, 
endoscopy can cause instrumental perforation, vertical 
mucosal lacerations, and emesis-induced rupture or tears 
in the esophageal lining tissue upon esophageal dilata-
tion. Sometimes, tearing happens spontaneously. In rare 
cases, spontaneous transmural esophageal perforation 
has also been noted [14, 114].
Esophageal Dysmotility
In older children and adults, intermittent dysphagia 
and food impactions are the 2 most common symptoms 
of EoE. However, in most cases, there is no underlying 
anatomical condition, which could lead to major esopha-
geal motility disorders [117, 118].
The etiopathogenesis is not well known for esophageal 
dysmotility. It may be associated with esophageal mucosa 
infiltration by eosinophils and its interactions with the 
microenvironment. It is unclear how eosinophilic infil-
tration might produce esophageal dysmotility; however, 
many speculations exist that the interaction of fibroblasts 
with eosinophils, eosinophil degranulation, binding of 
the eosinophil-derived major basic protein with musca-
rinic acetylcholine receptors, gastric eosinophilia, and in-
flammatory cytokines might be the leading causes of 
esophageal dysmotility [117].
According to Martin Martin et al. [118], pan-esopha-
geal pressurization is associated with bolus impaction in 
patients with EoE. Moreover, pan-esophageal pressuriza-
tion has been found to be the most common esophageal 
motor abnormality assessed by high-resolution manom-
etry.
Achalasia-Like Changes
Achalasia is an impaired peristaltic condition of the 
esophagus due to neuronal damage in myenteric plexus 
resulting in incomplete relaxation of the lower esopha-
geal sphincter. However, achalasia is rarely associated 
with EoE, the majority of patients with achalasia have ev-
idence of an abnormal buildup of eosinophils and/or 
their degranulation products in the esophageal muscula-
ris propria.
Esophageal eosinophilia may cause achalasia-like mo-
tility defects, likely by releasing myoactive and neuroac-
tive eosinophilic secretory products, which disrupt peri-
stalsis and interfere with lower esophageal sphincter re-
laxation, and by releasing profibrotic products causing 
tissue remodeling. Moreover, achalasia can also be caused 
by esophageal eosinophils by releasing cytotoxic eosino-
phil secretory products that destroy intramural neurons 
of the esophagus, which mediate peristalsis and lower 
esophageal sphincter relaxation. Hypothetically, it is un-
clear whether the destruction of enteric neurons in acha-
lasia is the cause of eosinophils infiltrating the esophageal 
muscular propria, nor clear that an antigen-driven EoE 
mainly involves the esophagus muscle, contributing to 
the development of abnormal esophageal motility [17, 
119]. A study by Surdea-Blaga et al. [17] reported a pa-
tient with EoE who underwent a high-resolution esopha-
geal manometry and upper gastrointestinal endoscopy 
for dysphagia and food impaction which revealed achala-
sia-like pattern, multiple white spots, along the entire 
esophagus with 39 eosinophils/HPF, eosinophilic micro-
abscesses, and basal zone hyperplasia. He was started on 
prednisone 25 mg/day, tapered to 5 mg/week. His symp-
toms relieved during the treatment; however, after stop-
ping the steroids, the dysphagia reappeared. Similarly, 
Landres et al. [120] reported EoE in a patient with vigor-
ous achalasia presented with epigastric pain, eosinophilic 
infiltration of the esophagus, and esophageal hypertro-
phy with predominant muscle layer involvement [120]. 
Further research is needed to investigate the role of eo-
sinophils in the pathogenesis of achalasia and other 
esophageal motility disorders.
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Intramucosal Dissection of the Esophagus
Acute intramucosal esophageal dissection is an un-
common complication of EoE [121, 122]. Acute intramu-
cosal dissection consists of the separation of mucosa and/
or submucosa from deeper muscular layers, resulting in 
the development of a false lumen [121, 122]. The risk of 
intramucosal dissection of the esophagus is increased in 
iatrogenic cases due to fragility of the esophageal mucosa, 
including routine endoscopy or endoscopic manipula-
tion with air insufflation, mucosal trauma during foreign 
body ingestion, and inflammatory conditions, such as 
EoE [121, 123].
Hepatic Portal Venous Gas
Hepatic portal venous gas is an uncommon condition 
in which intraluminal gas or gas produced by bacteria in 
the gastrointestinal tract enters the portal venous circula-
tion. It is often related to significant underlying patholo-
gies such as intestinal ischemia, sepsis, inflammatory 
bowel diseases, bowel obstruction, diverticulitis, appen-
dicitis, and trauma. Rarely, hepatic portal venous gas after 
an upper gastrointestinal endoscopy and dilation for be-
nign esophageal strictures with EoE has also been report-
ed in few studies [124, 125].
Adrenal Insufficiency
It is a condition of inadequate production of steroid 
hormones by adrenal glands, mainly cortisol; however, 
the aldosterone production can also be impaired. Recent-
ly, a children-based study reported 5% of cases of EoE, 
who were treated with topical corticosteroids, presented 
with adrenal insufficiency [126]. However, more data and 
research work are required to assess the efficacy of screen-
ing adrenal insufficiency in patients with EoE.
Conclusions
EoE is recently a more frequently occurring condition 
characterized by chronic inflammation and strictures. 
The etiology of EoE is multifactorial and most frequently 
occurs in patients with certain risk factors such as inflam-
matory mediators, genetic susceptibility, environmental 
factors, atopic conditions, and dietary products. Esopha-
geal involvement with eosinophils may be manifested as 
isolated or with coexisting conditions and should be tak-
en into consideration in the differential diagnosis. There 
could be a number of other contributing factors that can 
lead to EoE. Therefore, significant research studies are 
necessary to better understand the etiopathogenesis of 
EoE and its relationship with coexisting and correlated 
diseases.
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